Diane Marshall

Title: Diane Marshall: Innovator in Antibody Therapeutics

Introduction

Diane Marshall is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 6 patents to her name, Diane has established herself as a key figure in the fight against various diseases, including lung fibrosis.

Latest Patents

Diane's latest patents include groundbreaking work on antagonist antibodies that bind to human TGFB1, TGFB2, and TGFB3. These antibodies are designed for the treatment of lung fibrosis. The patent details the TGF-beta antibodies and their binding fragments, along with the DNA encoding these antibodies. It also discusses host cells that comprise this DNA and methods for expressing the antibodies or binding fragments in a host cell. Furthermore, the disclosure extends to pharmaceutical compositions that include the antibodies and their use in treating various diseases, including fibrosis. Another notable patent involves antibody molecules that specifically bind to TNF alpha, detailing their therapeutic uses and methods for production.

Career Highlights

Throughout her career, Diane has worked with notable companies such as UCB Biopharma Srl and UCB Biopharma Sprl. Her work in these organizations has contributed to advancements in antibody therapeutics and has positioned her as a leader in her field.

Collaborations

Diane has collaborated with esteemed colleagues, including Daniel John Lightwood and Graham Craggs. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Diane Marshall's contributions to the field of antibody therapeutics are noteworthy. Her innovative patents and collaborations highlight her commitment to advancing medical science. Diane continues to be a driving force in the development of treatments for complex diseases.